Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales

Abstract

Background The COVID-19 pandemic and ensuing national lockdowns have dramatically changed the healthcare landscape. The pandemic’s impact on people with chronic obstructive pulmonary disease (COPD) remains poorly understood. We hypothesised that the UK-wide lockdown restrictions were associated with reductions in severe COPD exacerbations. We provide the first national level analyses of the impact of the COVID-19 pandemic and first lockdown on severe COPD exacerbations resulting in emergency hospital admissions and/or leading to death as well as those recorded in primary care or emergency departments. Methods Using data from Public Health Scotland and the Secure Anonymised Information Linkage Databank in Wales, we accessed weekly counts of emergency hospital admissions and deaths due to COPD over the first 30 weeks of 2020 and compared these to the national averages over the preceding 5 years. For both Scotland and Wales, we undertook interrupted time-series analyses to model the impact of instigating lockdown on these outcomes. Using fixed-effect meta-analysis, we derived pooled estimates of the overall changes in trends across the two nations. Results Lockdown was associated with 48% pooled reduction in emergency admissions for COPD in both countries (incidence rate ratio, IRR 0.52, 95% CI 0.46 to 0.58), relative to the 5-year averages. There was no statistically significant change in deaths due to COPD (pooled IRR 1.08, 95% CI 0.87 to 1.33). In Wales, lockdown was associated with 39% reduction in primary care consultations for acute exacerbation of COPD (IRR 0.61, 95% CI 0.52 to 0.71) and 46% reduction in COPD-related emergency department attendances (IRR 0.54, 95% CI 0.36 to 0.81). Conclusions The UK-wide lockdown was associated with the most substantial reductions in COPD exacerbations ever seen across Scotland and Wales, with no corresponding increase in COPD deaths. This may have resulted from reduced transmission of respiratory infections, reduced exposure to outdoor air pollution and/or improved COPD self-management.

The overall impact of COVID‐19 on healthcare during the pandemic: A multidisciplinary point of view

“…Similar results were found in the case of chronic obstructive pulmonary disease (COPD) with the most substantial reductions ever seen across Scotland and Wales which is hypothesized to have resulted from the decreased transmission of respiratory infection and exposure to outdoor pollution as well as possible enhanced COPD self‐management. 159 …”

Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study

“…Concerning moderate AECOPD, the meta-analysis revealed no conclusive results regarding the impact of the pandemic. However, a population-based study from Scotland and Wales found a reduction of primary care consultation for AECOPD 12 …”

Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported information

“…Patients with chronic diseases may choose to shield during this period, which may then negatively impact their activity and quality of life [ 20 ]. Previous studies have also reported reduction in asthma and COPD related health visits since the start of the pandemic in the UK [ 21 – 23 ]. Whether this is due to real reductions in asthma and COPD exacerbations or due to changes in health-seeking behavior warrants further investigations.…”